CAS 1236699-92-5
:Pimasertib
Description:
Pimasertib, with the CAS number 1236699-92-5, is a small molecule inhibitor that primarily targets the mitogen-activated protein kinase (MAPK) pathway, specifically the MEK1 and MEK2 enzymes. It is classified as a selective MEK inhibitor and has been investigated for its potential therapeutic applications in various cancers, particularly those with mutations in the RAS or RAF genes. Pimasertib exhibits characteristics such as moderate solubility in organic solvents and a relatively low molecular weight, which facilitates its absorption and distribution in biological systems. The compound has been studied in clinical trials, often in combination with other anticancer agents, to enhance therapeutic efficacy and overcome resistance mechanisms. Its mechanism of action involves the inhibition of downstream signaling pathways that promote cell proliferation and survival, making it a candidate for targeted cancer therapy. As with many investigational drugs, the safety profile and pharmacokinetics of Pimasertib are critical areas of ongoing research to determine its clinical utility.
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 8 products.
4-Pyridinecarboxamide, N-[(2S)-2,3-dihydroxypropyl]-3-[(2-fluoro-4-iodophenyl)amino]-
CAS:Formula:C15H15FIN3O3Purity:98%Color and Shape:SolidMolecular weight:431.2008Pimasertib
CAS:<p>Pimasertib (AS703026) is an orally bioavailable small-molecule inhibitor of MEK1 and MEK2 (MEK1/2) with potential antineoplastic activity.</p>Formula:C15H15FIN3O3Purity:98.25% - 99.57%Color and Shape:SolidMolecular weight:431.2AS-703026
CAS:<p>AS-703026</p>Formula:C15H15FIN3O3Purity:99.8% (Typical Value in Batch COA)Color and Shape: pale yellow solidMolecular weight:431.20g/molPimasertib
CAS:<p>A selective inhibitor of MEK1/2 kinase. Anti-proliferative and pro-apoptotic in multiple myeloma (MM) cells via G0/G1 cell cycle arrest and caspase 3 and PARP cleavage, respectively. Synergistic with other anti-MM therapies. Has anti-tumor effects in some solid tumors, such as in K-ras mutated colorectal cancer.</p>Formula:C15H15FIN3O3Purity:Min. 95%Color and Shape:White To Yellow SolidMolecular weight:431.2 g/mol
![4-Pyridinecarboxamide, N-[(2S)-2,3-dihydroxypropyl]-3-[(2-fluoro-4-iodophenyl)amino]-](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb%2FDA000KXC.jpg&w=3840&q=75)
